Search

Home > New FDA Approvals > 117 - Symfi™ once-daily HIV combo; FDA working on a 'dozen' policies to boost copycat biotech drugs; FDA panel backs approval of lofexidine for opioid withdrawal.
Podcast: New FDA Approvals
Episode:

117 - Symfi™ once-daily HIV combo; FDA working on a 'dozen' policies to boost copycat biotech drugs; FDA panel backs approval of lofexidine for opioid withdrawal.
Category: Science & Medicine
Duration: 00:08:36
Publish Date: 2018-03-29 06:59:21
Description:

March 29, 2018 

Please subscribe, rate and review if you like this podcast. Thank you! The podcast website is http://newfdaapprovals.com 

1.02 Mylan Introduces Symfi™ Triple Combo Once-Daily HIV Treatment in the U.S.

https://www.prnewswire.com/news-releases/mylan-introduces-symfi-triple-combo-once-daily-hiv-treatment-in-the-us-300620647.html

2.16 FDA working on a 'dozen' policies to boost copycat biotech drugs https://www.reuters.com/article/us-usa-healthcare-gottlieb/fda-working-on-a-dozen-policies-to-boost-copycat-biotech-drugs-idUSKBN1H41WN

4.02 FDA panel backs approval of lofexidine for opioid withdrawal https://www.medscape.com/viewarticle/894510

Udemy course Freelance Medical Writing as a Career Choice. This is a 35-minute course giving an overview of what qualifications are needed, what skills and attributes are helpful and how much money you can make.

https://www.udemy.com/freelance-medical-writing-career/?couponCode=MEDICALWRITING

Music credit: freemusicarchive.org/music/MindsEye/Yellow_Taxi/
Total Play: 0